Geneva, June 4 -- International Clinical Trials Registry received information related to the study (NCT06979427) titled 'CTFFR and Prediction of Non-Significant CAD Lesions' on May 16.

Study Type: Interventional

Study Design: Allocation: Non-Randomized. Intervention model: Parallel Assignment. Primary purpose: Diagnostic. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).

Primary Sponsor: Shiraz University of Medical Sciences

Condition: Chronic Coronary Syndrome

Intervention: Diagnostic Test: NIFFR

Recruitment Status: Recruiting

Phase: N/A

Date of First Enrollment: January 1, 2024

Target Sample Size: 250

Countries of Recruitment: Iran, Islamic Republic of

To know more, visit https://clinica...